know more, do more

Advancing endocrinology and improving public health

Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field. 

the latest
Meetings & Events

Register Today for ENDO 2025 in San Francisco

May 06, 2025

Join us in San Francisco, CA, USA, July 12-15, 2025, for ENDO 2025. With over 7,000 attendees, nearly 2,500 abstracts and over 200 other sessions, ENDO is the leading global meeting on endocrinology research and clinical care. ENDO’s comprehensive program provides attendees the opportunity to learn about the latest developments in hormone science and medicine from renowned investigators, expert clinicians, and educators from all over the world. Register Today

Awards

Transatlantic Alliance Award Nominations Are Open

April 01, 2025

The Transatlantic Alliance Award honors a leading endocrinologist whose collaborative work has advanced research across Europe and the United States. Submit your nomination to recognize a global leader in basic or clinical endocrinology. Nominations for 2026 close July 30, 2025.

Store

Now Available: Pediatric ESAP™ 2025–2026

April 14, 2025

Navigate the complexities of endocrine care for children and adolescents with the Pediatric Endocrine Self-Assessment Program (ESAP)™ 2025–2026. Enhance patient care with 100 new case-based questions covering growth, diabetes, reproduction, and more. Available in print, eBook, and online, with interactive modes to build knowledge and confidence. Order now.

Training & Education

Obesity Fellows Program Application Period Now Open

April 17, 2025

Applications are now being accepted for the 2025 Obesity Fellows Program, September 19-20, a blended learning experience on best practices in obesity care, exclusively for endocrinology fellows. Travel, two-night hotel accommodation, and meal expenses will be covered for up to 50 US-domestic fellows. Applications are due Friday, May 9 at 11:59 PM ET.

Advocacy

Advocacy in Action

May 02, 2025

The Senate Appropriations Committee held a hearing on the importance of funding Biomedical Research; the Society invites members to join us in our advocacy efforts to amplify our message. The Society also submitted a statement to EU representatives supporting certain provisions regarding EDC regulations.

We Are Endocrinology

Deena Adimoolam
“I use media to share a message of prevention and recognition of many endocrine diseases, especially diabetes and obesity. As a member of the Endocrine Society, I have also had the opportunity to continue this work with Society members who share in my vision and passion. I work closely with the Endocrine Society’s Hormone Health Network to spread awareness on various endocrine diseases through patient education tools and media.” – Deena Adimoolam, MD
We are an 18,000 member strong global community
A champion for the Society’s guidelines, Chris has been passionate about improving our guideline development methodology as well as about making guideline content more accessible to readers around the world. – Christopher McCartney, MD

Advantages of Membership

Need more info?

Learn more about the advantages of membership

Endocrine Society News

Hoshino Wins Wayne Bardin International Travel Award

April 23, 2025

The Endocrine Society has selected Yoshitomo Hoshino, M.D., Ph.D., as the recipient of its 2025 C. Wayne Bardin, M.D., International Travel Award for his outstanding ENDO abstract and research contributions to the care of patients with bone health disorders.

Endocrine Society names Tena-Sempere as next Editor-in-Chief of Endocrinology

April 22, 2025

The Endocrine Society has appointed Manuel Tena-Sempere, M.D., Ph.D., of the University of Cordoba in Spain, as the next Editor-in-Chief of its flagship basic science journal, Endocrinology, starting January 2026.

Endocrine Society disappointed in failure to extend Medicare and Medicaid coverage to anti-obesity medications

April 07, 2025

The Endocrine Society is extremely disappointed the administration has chosen not to finalize a rule that would have made anti-obesity medications more accessible to millions of Americans with obesity.

View More

Featured Journal Articles

Refractory Hypoglycemia Secondary to the Warburg Effect in Diffuse Large B-Cell Lymphoma

May 06, 2025

The authors present a 62-year-old woman with a 10-year history of type 2 diabetes mellitus who presented with abdominal pain and spontaneous hypoglycemia despite discontinuation of her diabetic treatments.

Osilodrostat Treatment for Adrenal and Ectopic Cushing Syndrome

May 06, 2025

Here we use illustrative case studies to discuss practical considerations for the management of patients with ectopic or adrenal Cushing syndrome and review published data on the use of osilodrostat in these patients.

Gonadotropin Therapy for Mini-Puberty Induction in Male Infants With Hypogonadotropic Hypogonadism

May 06, 2025

We conducted a systematic review of the effectiveness of gonadotropin therapy in stimulating mini-puberty related outcomes in male infants with congenital hypogonadotropic hypogonadism.

View More
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.